Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens

Ítems similars

• Identification of neoantigen-reactive tumor-infiltrating lymphocytes in primary bladder cancer
  per: Leko, Vid, et al.
  Publicat: (2019)
• An effective mouse model for adoptive cancer immunotherapy targeting neoantigens
  per: Hanada, Ken-ichi, et al.
  Publicat: (2019)
• Persistence of Tumor Infiltrating Lymphocytes in Adoptive Immunotherapy Correlates With Telomere Length
  per: Shen, Xinglei, et al.
  Publicat: (2007)
• Adoptively transferred tumor-infiltrating T cells target somatic cancer mutations in a human papillomavirus+ cancer patient with complete tumor regression
  per: Stevanović, Sanja, et al.
  Publicat: (2015)
• Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing
  per: Lu, Yong-Chen, et al.
  Publicat: (2021)